Literature DB >> 163979

Hybridisation of Dane particle DNA with the free plasma DNA of hepatitis carriers.

P P Hung, J C Mao, C M Ling, L R Overby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 163979     DOI： 10.1038/253571a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

1.  DNA-binding antibodies and hepatitis B markers in acute and chronic liver disease.

Authors:  J G Kingham; S Rassam; N Ganguly; M J Mcguire; B Nasrat; S T Holgate; D R Triger; R Wright
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

2.  Molecular hybridization methods for determination of serum HBV-DNA.

Authors:  T Arima; S Torigoe; H Hada; S Morichika; K Togawa; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-10

3.  DNA of free and complexed origin in human plasma: concentration and length distribution.

Authors:  R H Dennin
Journal:  Klin Wochenschr       Date:  1979-05-03

Review 4.  The nature of the hepatitis B virus and its mode of replication.

Authors:  C R Howard
Journal:  Springer Semin Immunopathol       Date:  1981-04

Review 5.  The hepatitis B virus and its DNA polymerase: the prototype three-D virus.

Authors:  S Z Hirschman
Journal:  Mol Cell Biochem       Date:  1979-07-15       Impact factor: 3.396

6.  Circulating DNA in systemic lupus erythematosus. Isolation and characterization.

Authors:  C R Steinman
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

7.  Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone.

Authors:  P M Rumore; C R Steinman
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

8.  Association of e antigen with Dane particle DNA in sera from asymptomatic carriers of hepatitis B surface antigen.

Authors:  B G Werner; A P O'Connell; J Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

9.  Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon.

Authors:  J G Kingham; N K Ganguly; Z D Shaari; R Mendelson; M J McGuire; S J Holgate; T Cartwright; G M Scott; B M Richards; R Wright
Journal:  Gut       Date:  1978-02       Impact factor: 23.059
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.